...is now US$7.6 billion.

By comparison, RVX is at less than US$500 million.  

So if Phase 3 is a success, does that mean we can aim for US$7.5 billion?  Fish oil with substitutes, one trick pony company vs RVX?  

I would like to say it is not a fair competition...but then there is this issue of Zenith taking a large part of top line sales as royalties.

Even allowing for a 10% dilution, I think it is easy to justify a US$7 billion value for RVX (so around C$40)...assuming Phase 3 results are what we expect them to be.